This bill mandates coverage for genetic testing for inherited gene mutations and evidence-based cancer imaging for certain individuals in Arkansas. It introduces a new subchapter to the Arkansas Code, specifically outlining definitions related to clinical utility, evidence-based cancer imaging, and genetic testing. The bill stipulates that starting January 1, 2026, health benefit plans must provide coverage for genetic testing in clinical settings for individuals with a personal or family history of cancer, as long as the testing is clinically useful and recommended by a healthcare provider. Additionally, it requires coverage for evidence-based cancer imaging for individuals with a previous cancer diagnosis, contingent upon similar criteria.

The bill also includes provisions regarding health savings accounts, indicating that if the application of the coverage would affect eligibility for these accounts, it will only apply to those with qualified high deductible health plans after the minimum deductible is met. Furthermore, the Insurance Commissioner is tasked with promulgating rules to implement and administer the new subchapter. Overall, the legislation aims to enhance access to critical genetic testing and imaging services for individuals at risk of cancer.